Vantera Mediated Quantification of Urine Citrate and Creatinine: A New Technology to Assess Risk of Nephrolithiasis

Vantera Mediated Quantification of Urine Citrate and Creatinine: A New Technology to Assess Risk of Nephrolithiasis

Urine citrate is often used to identify patients at risk of recurrent nephrolithiasis or kidney stones. A high-throughput assay was developed to measure urine citrate and creatinine on the Vantera<sup>®</sup> Clinical Analyzer, a nuclear magnetic resonance (NMR) instrument designed for t...

Full description

Bibliographic Details
Main Authors: Steven P. Matyus, Justyna Wolak-Dinsmore, Erwin Garcia, Randolph M. Young, Margery A. Connelly
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Diagnostics
Subjects:
citrate
creatinine
nuclear magnetic resonance spectroscopy
nephrolithiasis
kidney stones
Vantera Clinical Analyzer
Online Access:https://www.mdpi.com/2075-4418/12/11/2606

Internet

https://www.mdpi.com/2075-4418/12/11/2606

Similar Items